News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Karson Tse

Articles by Karson Tse

17 TROPION-Breast05: A Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Chemotherapy (CT) Plus Pembrolizumab in Patients (pts) With PD-L1–Positive Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (TNBC)

17 TROPION-Breast05: A Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Chemotherapy (CT) Plus Pembrolizumab in Patients (pts) With PD-L1–Positive Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (TNBC)

ByStephanie L. Graff, MD,Peter Schmid, MD,Massimo Cristofanilli, MD,David W. Cescon,Tina Hovey,Karson Tse,Petra Vuković,Joyce O’Shaughnessy, MD

August 11th 2024

Latest Updated Articles

Trending on CancerNetwork

How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?

Real-World Data From IMS: Promising Results in Relapsed/Refractory Multiple Myeloma

Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma

Leveraging Novel Software to Further Improve Personalized Cancer Care

FDA Grants FTD to Novel Cancer Vaccine in Low Tumor Burden Follicular Lymphoma

© 2025 MJH Life Sciences^®

All rights reserved.